Dr. Sinha is an experienced synthetic and medicinal chemist. She is working on Gleevec-related projects, creating entirely novel molecules, purifying them and testing them in Alzheimer’s disease animal models. In collaboration with Dr. Bustos, she is also developing compounds for CK1 and autophagy-related projects.
